NIT
VYGR icon

NumerixS Investment Technologies’s Voyager Therapeutics VYGR Stock Holding History

NumerixS Investment Technologies’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-5,700
Closed -$80K – 1301
2019
Q4 		$80K Sell
5,700
-3,500
-38% -$50.9K 0.02% 729
2019
Q3 		$158K Buy
9,200
+8,100
+736% +$170K 0.04% 443
2019
Q2 		$30K Buy
+1,100
New +$25.2K 0.01% 864
2018
Q4 		– Sell
-5,025
Closed -$94K – 1402
2018
Q3 		$94K Sell
5,025
-575
-10% -$11K 0.02% 824
2018
Q2 		$114K Sell
5,600
-900
-14% -$17.8K 0.03% 709
2018
Q1 		$119K Buy
+6,500
New +$140K 0.03% 599

Other funds holding VYGR

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

NumerixS Investment Technologies's VYGR Position: Q1 2020 in Review

NumerixS Investment Technologies sold out of Voyager Therapeutics (VYGR) in Q1 2020, closing a stake of 5,700 shares — an estimated $80K sold.

NumerixS Investment Technologies first reported a position in VYGR in Q1 2018 and held it in 6 quarters. The position peaked at $158K in Q3 2019. 121 funds tracked by Wall St. Rank hold VYGR as of Q1 2020.

  • NumerixS Investment Technologies reported no remaining Voyager Therapeutics position as of Q1 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 5,700 Voyager Therapeutics shares in Q1 2020, an estimated $80K.
  • NumerixS Investment Technologies first reported a position in Voyager Therapeutics in Q1 2018 and held it in 6 quarters.
  • NumerixS Investment Technologies's Voyager Therapeutics position peaked at $158K in Q3 2019.
  • 121 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2020.

Based on NumerixS Investment Technologies's 13F filing for Q1 2020, filed 15 May 2020.